Abstract:Recently, we established a new mouse model of vein graft arteriosclerosis by grafting vena cava to carotid arteries. In many respects, the morphological features of this murine vascular graft model resemble those of human venous bypass graft disease. Using this model, we studied the effects of local gene transfer of tissue inhibitor of metalloproteinase-2 (TIMP-2) on vein graft remodeling. Mouse isogeneic vessels of the vena caval veins were grafted end to end into carotid arteries, then enveloped with the replication-defective recombinant adenoviruses overexpressing human TIMP-2 (RAdTIMP-2) or beta-galactosidase (RAdLacZ) at 1x10(10) plaque-forming units/mL in a total volume of 50 microL, and incubated at room temperature for 20 minutes. In the untreated group, vessel wall thickening was observed as early as 1 week after surgery and progressed to 4- to 10-fold the original thickness in grafted veins at 4 and 8 weeks, respectively. RAdLacZ vector treatment significantly enhanced neointimal lesions at 8 weeks, which was completely blocked by RAdTIMP-2 gene overexpression. Interestingly, RAdTIMP-2 gene transfer resulted in a reduction in vessel diameter of grafted veins compared with ungrafted veins (819+/-96 versus 624+/-67 microm, respectively; P<0.05). Maximal beta-galactosidase activity was found at 2 weeks and was detectable until 4 weeks after gene transfer. Double immunofluorescence studies demonstrated that cells overexpressing TIMP-2 were mostly localized in the adventitia and were MAC-1-positive monocytes/macrophages but not smooth muscle cells. Furthermore, the activity of matrix metalloproteinases was markedly decreased in the vessel walls treated with RAdTIMP-2 compared with that in the untreated control group and the RAdLacZ-treated group. Thus, this mouse model has been proven to be useful in gene transfer studies. Our findings demonstrate that local TIMP-2 gene transfer significantly reduces vein graft diameter, ie, remodeling to an artery-like vessel via inhibition of matrix metalloproteinase activity.

Loss of P53 Accelerates Neointimal Lesions of Vein Bypass Grafts in Mice

Reduced Neointima Hyperplasia of Vein Bypass Grafts in Intercellular Adhesion Molecule-1–Deficient Mice

AIP1 Prevents Graft Arteriosclerosis by Inhibiting Interferon-γ–Dependent Smooth Muscle Cell Proliferation and Intimal Expansion

Accelerated Arteriosclerosis of Vein Grafts in Inducible NO Synthase −/− Mice is Related to Decreased Endothelial Progenitor Cell Repair

Accelerated Atherosclerosis and Calcification in Vein Grafts

Biomechanical Stress-Induced Apoptosis in Vein Grafts Involves P38 Mitogen-Activated Protein Kinases

Mouse Model of Venous Bypass Graft Arteriosclerosis

Prolonged survival of heart allografts from p53-deficient mice.

New Mouse Model of Vein Bypass Graft Atherosclerosis

Lack of Interleukin-1 Signaling Results in Perturbed Early Vein Graft Wall Adaptations.

Defective Autophagy Triggered by Arterial Cyclic Stretch Promotes Neointimal Hyperplasia in Vein Grafts Via the P62/nrf2/slc7a11 Signaling Pathway.

Rapid Development of Vein Graft Atheroma in ApoE-deficient Mice

Vein graft disease in a knockout mouse model of hyperhomocysteinaemia

P38 MAPK Inhibitor, CBS3830 Limits Vascular Remodelling in Arterialised Vein Grafts.

Long-Term Engraftment of Bone Marrow-Derived Cells in the Intimal Hyperplasia Lesion of Autologous Vein Grafts

Local Gene Transfer of Tissue Inhibitor of Metalloproteinase-2 Influences Vein Graft Remodeling in a Mouse Model

Inhibition of Neointima Hyperplasia of Mouse Vein Grafts by Locally Applied Suramin

Identification of PI3K regulatory subunit p55γ as a novel inhibitor of vascular smooth muscle cell proliferation and neointimal formation.

Exacerbated Vein Graft Arteriosclerosis in Protein Kinase Cδ–null Mice

Mouse Model Of Transplant Arteriosclerosis - Role Of Intercellular Adhesion Molecule-1

Characterization of Neointima Lesions Associated with Arteriovenous Fistulas in a Mouse Model.